Comparison Between Pioglitazone and SES With type2 DM
Status:
Completed
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
Drug-eluting stents have been shown to decrease restenosis, but were associated with an
increased rate of death, as compared with bare-metal stents. Recently, thiazolidinediones
effectively reduced restenosis and the risk of repeat target vessel revascularization. We
conducted a study to compare the performance of a drug-eluting stent with that of a
bare-metal stent with pioglitazone in patients with type 2 diabetic mellitus.